Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Neil

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Cancer Chemotherapy Reports|May 1, 1974
Antitumor activity and mode of action of 2-thio-6-azauridine (NSC-146268) on L1210 leukemiaL H Li, G L Neil, T E Moxley, et al.
Cancer Chemotherapy Reports|November 1, 1975
Phase I study of 5-azacytidine (NSC-102816) using 24-hour continuous infusion for 5 daysP L Lomen, L H Baker, G L Neil, et al.
Cancer Research|March 1, 1976
Combination chemotherapy of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine and 5-azacytidineG L Neil, A E Berger, B K Bhuyan, et al.
Cancer Chemotherapy Reports|December 1, 1972
Antileukemic activity of streptozotocin (NSC-85998) and its analogsB K Bhuyan, T J Fraser, H H Buskirk, et al.
Diabetes|September 1, 1974
Placental transfer of streptozotocin in the rhesus monkeyW A Reynolds, R A Chez, B K Bhuyan, et al.
Cancer Clinical Trials|January 1, 1981
Acivicin. An antitumor antibioticD S Poster, S Bruno, J Penta, et al.
Medicinal Research Reviews|July 1, 1993
Biotechnology in the drug discovery process: strategic and management issuesM Williams, T Giordano, R A Elder, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1975
Varicella-zoster virus and subcutaneous cytarabine: correlation of in vitro sensitivities to blood levelsD A Zaky, R F Betts, R G Douglas, et al.
Cancer Research|March 1, 1979
Biochemical and pharmacological effects of the fermentation-derived antitumor agent, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125)G L Neil, A E Berger, R P McPartland, et al.
Cancer Chemotherapy Reports|May 1, 1975
Enhancement by tetrahydrouridine (NSC-112907) of the oral activity of 5-azacytidine (NSC-102816) in L1210 leukemic miceG L Neil, T E Moxley, S L Kuentzel, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Cancer Chemotherapy Reports|May 1, 1974
Antitumor activity and mode of action of 2-thio-6-azauridine (NSC-146268) on L1210 leukemiaL H Li, G L Neil, T E Moxley, et al.
Cancer Chemotherapy Reports|November 1, 1975
Phase I study of 5-azacytidine (NSC-102816) using 24-hour continuous infusion for 5 daysP L Lomen, L H Baker, G L Neil, et al.
Cancer Research|March 1, 1976
Combination chemotherapy of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine and 5-azacytidineG L Neil, A E Berger, B K Bhuyan, et al.
Cancer Chemotherapy Reports|December 1, 1972
Antileukemic activity of streptozotocin (NSC-85998) and its analogsB K Bhuyan, T J Fraser, H H Buskirk, et al.
Diabetes|September 1, 1974
Placental transfer of streptozotocin in the rhesus monkeyW A Reynolds, R A Chez, B K Bhuyan, et al.
Cancer Clinical Trials|January 1, 1981
Acivicin. An antitumor antibioticD S Poster, S Bruno, J Penta, et al.
Medicinal Research Reviews|July 1, 1993
Biotechnology in the drug discovery process: strategic and management issuesM Williams, T Giordano, R A Elder, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1975
Varicella-zoster virus and subcutaneous cytarabine: correlation of in vitro sensitivities to blood levelsD A Zaky, R F Betts, R G Douglas, et al.
Cancer Research|March 1, 1979
Biochemical and pharmacological effects of the fermentation-derived antitumor agent, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125)G L Neil, A E Berger, R P McPartland, et al.
Cancer Chemotherapy Reports|May 1, 1975
Enhancement by tetrahydrouridine (NSC-112907) of the oral activity of 5-azacytidine (NSC-102816) in L1210 leukemic miceG L Neil, T E Moxley, S L Kuentzel, et al.
Pageof 5